Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial

被引：0
|
作者：
Vandenbosch, F. [1 ]
McHugh, N. J. [2 ]
Reece, R. [3 ]
Cooper, R. [4 ]
Manger, B. [5 ]
Goupille, P. [6 ]
FitzGerald, O. [7 ]
Kron, M. [8 ]
Frank, M. [8 ]
Kupper, H. [8 ]
Roedevand, E. [9 ]
Holck, P. [10 ]
VanVollenhoven, R. [11 ]
Leirisalo-Repo, M. [12 ]
机构：
[1] Univ Hosp, Ghent, Belgium
[2] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[3] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[4] Hope Hosp, Salford M6 8HD, Lancs, England
[5] Univ Erlangen Nurnberg, Erlangen, Germany
[6] CHU Tours, Hop Trousseau, Tours, France
[7] St Vincents Univ Hosp, Dublin, Ireland
[8] Abbott GmbH & Co KG, Ludwigshafen, Germany
[9] St Olavs Hosp, Trondheim, Norway
[10] Silkeborg Centralsygehus, Silkeborg, Denmark
[11] Karolinska Univ Hosp, Stockholm, Sweden
[12] Univ Hosp, Helsinki, Finland
来源：
RHEUMATOLOGY | 2007年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：I52 / I53
页数：2
相关论文
共 50 条
  • [21] Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Annunziata Dattola
    Maria Vittoria Cannizzaro
    Mauro Mazzeo
    Luca Bianchi
    Dermatology and Therapy, 2017, 7 : 485 - 492
  • [22] Reliability and validity of the work limitations questionnaire (WLQ) and impact of adalimumab (HUMIRA®) on presenteeisna for patients with psoriatic arthritis (PsA):: Results of ACCLAIM.
    Gladman, Daftia D.
    Sampalis, John S.
    Martel, M. J.
    Gooch, Katherine L.
    Wong, Robert
    Guerette, Benoit
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S202 - S202
  • [23] Efficacy and safety of adalimumab in the treatment of Rheumatoid Arthritis (RA) in real-life clinical practice: 1-year-results of the react study
    Burmester, G. R.
    Wordsworth, P.
    Saez, I. Monteagudo
    Malaise, M. G.
    Kary, S.
    Kupper, H.
    RHEUMATOLOGY, 2006, 45 : I43 - I43
  • [24] Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Annunziata Dattola
    Maria Vittoria Cannizzaro
    Mauro Mazzeo
    Luca Bianchi
    Dermatology and Therapy, 2018, 8 : 171 - 171
  • [25] CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRY
    Bilgin, E.
    Duran, E.
    Bolek, E. C.
    Farisogullari, B.
    Yardimci, G. K.
    Kilic, L.
    Akdogan, A.
    Bilgen, S. A.
    Karadag, O.
    Ertenli, A. I.
    Kiraz, S.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1663 - 1663
  • [26] Adalimumab treatment effects on quality of life in patients with psoriatic arthritis: Results from adept
    Gladman, DD
    Mease, PJ
    Emery, R
    Wellborne, F
    Combe, B
    Weinberg, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 317 - 317
  • [27] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [28] Adalimumab and etanercept adherence, persistence and switch in the treatment of psoriatic arthritis: 10-year real-life analysis
    Santoleri, Fiorenzo
    Romagnoli, Alessia
    Costantini, Alberto
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (01) : 93 - 97
  • [29] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE CLINICAL PRACTICE
    Cardenas, M.
    de la Fuente, S.
    Font-Ugalde, P.
    Castro-Villegas, M. C.
    Romero-Gomez, M.
    Ruiz-Vilchez, D.
    Calvo-Gutierrez, J.
    Ortega-Castro, R.
    Escudero-Contreras, A.
    Casado, M. A.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 703 - 703
  • [30] First line treatment of metastatic colorectal cancer: Are clinical trial results reproducible in real-life practice?
    Lewin, Ron
    Gal, Omer
    Sulkes, Aaron
    Gordon, Noa
    Ben-Aharon, Irit
    Purim, Ofer
    Perel, Gali
    Kundel, Yulia
    Moore, Assaf
    Ulitsky, Olga
    Brenner, Baruch
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345